Polysomnographic features of REM sleep behavior disorder

  title={Polysomnographic features of REM sleep behavior disorder},
  author={Odile Lapierre and Jacques Y. Montplaisir},
  pages={1371 - 1371}
REM sleep behavior disorder (RBD) is characterized by the intermittent absence of REM sleep EMG atonia and the appearance of elaborate motor activity associated with dream mentation. There are no specific diagnostic criteria for RBD based upon polysomnographic findings. We describe a new scoring method and show its sensitivity to treatment with clonazepam. An increased phasic submental EMG density occurs in RBD patients, but REM density is similar to that of controls. Clonazepam selectively… 
REM Sleep Behavior Disorder in Narcolepsy with Cataplexy
Several clinical and polysomnographic aspects seem to differentiate RBD in patients with narcolepsy from idiopathic or secondary RBD, suggesting the involvement of specific neurophysiological, neurochemical and neuropathological substrates.
REM sleep behavior disorder.
  • É. Frenette
  • Psychology, Medicine
    The Medical clinics of North America
  • 2010
Clinical neurophysiology of REM parasomnias.
REM Sleep Behavior Disorder
Melatonin therapy for REM sleep behavior disorder
Melatonin was reconfirmed to be effective in RBD symptoms, especially for patients with low melatonin secretion, while its mechanism was not clearly known in the present study.
Treatment of REM Sleep Behavior Disorder
There is no clear evidence of beneficial effect of bilateral subthalamic nucleus stimulation despite the improvement of the sleep architecture, and the effect of acetylcholinesterase inhibitors and dopaminergics on RBD symptoms needs future validation.
REM sleep behavior disorder (RBD)
This review article presents the current knowledge regarding RBD diagnosis and treatment, and the best-researched treatments for RBD are clonazepam and melatonin.
REM Behavior Disorder in Adults
Given the relationship of RBD to neurodegenerative conditions, RBD represents a unique opportunity to understand the neuroanatomical basis for REM sleep-related mechanisms and may be a leading indicator for patients who may benefit from neuroprotective treatments for these neurodegnerative diseases.


Clonazepam treatment of insomnia due to sleep myoclonus.
Small doses of clonazepam, 1 mg, before retiring were found to specifically control the myoclonus and allow sleep patterns to return to normal.
Nocturnal myoclonus: treatment efficacy of clonazepam and temazepam.
The data support clinical reports that clonazepam, a benzodiazepine marketed for the indication of seizure, is useful in improving sleep disturbances associated with nocturnal myoclonus and suggest the need for a model that explains why leg movements and sleep disturbances may wax and wane independently.
The relationship of excessive exploratory behavior in wakefulness to paradoxical sleep without atonia.
The argument that peripheral motor inhibition during PS depends on suppression of a brainstem locomotor region in addition to direct inhibition of spinal motor neurons is developed.
Temporal sequence and unit composition in dream reports from different stages of sleep.
The results suggest that most inter-stage differences in dream "quality" are, in fact, by-products of inter- stage differences indream quantity, but that there are residual stage differences that can coherently be attributed neither to differences in the continuity with which dream production processes are activated in different stages nor to Differences in dream retrieval from different stages.
A re-evaluation of the effects of lesions of the pontine tegmentum and locus coeruleus on phenomena of paradoxical sleep in the cat.
The conclusion drawn from these experiments and from a review of the literature is that the hypotheses stating that the locus coeruleus or other isolated nuclei of the pons are specifically concerned with the initiation of paradoxical sleep are not clearly supported by available evidence.
Clonazepam and vibration in restless legs syndrome
In 6 patients with RLS, a randomized double‐blind cross‐over trial vs placebo showed a significant efficacy of clonazepam in improving subjective quality of sleep and leg dysaesthesia.
Clinical, biochemical, and physiological features distinguishing myoclonus responsive to 5-hydroxytryptophan, tryptophan with a monoamine oxidase inhibitor, and clonazepam.
The neurochemical basis of myoclonus responding to 5HT precursors and clonazepam is discussed and it is suggested that such myOClonus arises from a relative hypoactivity of the 5HT neuronal system which results in a release of abnormal responses to sensory stimuli which characterize this type of my Coclonus.